Barbara Sprague Herrmann, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vestibular Evoked Myogenic Potentials | 16 | 2021 | 88 | 2.450 |
Why?
|
| Auditory Brain Stem Implants | 8 | 2024 | 32 | 1.550 |
Why?
|
| Auditory Brain Stem Implantation | 6 | 2024 | 15 | 1.350 |
Why?
|
| Meniere Disease | 8 | 2021 | 164 | 1.120 |
Why?
|
| Cochlear Implantation | 13 | 2022 | 316 | 1.050 |
Why?
|
| Hearing Loss, Sensorineural | 13 | 2021 | 781 | 0.950 |
Why?
|
| Speech Perception | 9 | 2024 | 508 | 0.890 |
Why?
|
| Semicircular Canals | 8 | 2021 | 203 | 0.870 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 6 | 2019 | 253 | 0.840 |
Why?
|
| Labyrinth Diseases | 4 | 2019 | 151 | 0.810 |
Why?
|
| Cochlear Implants | 8 | 2022 | 339 | 0.730 |
Why?
|
| Saccule and Utricle | 5 | 2019 | 81 | 0.680 |
Why?
|
| Audiometry | 10 | 2022 | 253 | 0.640 |
Why?
|
| Vestibule, Labyrinth | 7 | 2019 | 234 | 0.640 |
Why?
|
| Vestibular Function Tests | 5 | 2019 | 128 | 0.560 |
Why?
|
| Hearing Loss, Central | 1 | 2015 | 14 | 0.500 |
Why?
|
| Neck Muscles | 4 | 2019 | 100 | 0.480 |
Why?
|
| Cochlea | 6 | 2017 | 844 | 0.410 |
Why?
|
| Deafness | 6 | 2024 | 459 | 0.410 |
Why?
|
| Temporal Bone | 6 | 2021 | 683 | 0.390 |
Why?
|
| Vestibular Nerve | 3 | 2019 | 101 | 0.390 |
Why?
|
| Neuroma, Acoustic | 1 | 2015 | 458 | 0.370 |
Why?
|
| Neurofibromatosis 2 | 4 | 2021 | 383 | 0.370 |
Why?
|
| Bone Conduction | 2 | 2022 | 102 | 0.300 |
Why?
|
| Evoked Potentials, Auditory | 4 | 2006 | 531 | 0.300 |
Why?
|
| Electromyography | 6 | 2019 | 1393 | 0.290 |
Why?
|
| Auditory Perception | 2 | 2017 | 583 | 0.290 |
Why?
|
| Ear, Inner | 4 | 2024 | 425 | 0.280 |
Why?
|
| Acoustic Stimulation | 7 | 2019 | 1235 | 0.270 |
Why?
|
| Hearing Loss, Bilateral | 2 | 2017 | 53 | 0.270 |
Why?
|
| Acoustic Impedance Tests | 2 | 2005 | 110 | 0.260 |
Why?
|
| Ear Canal | 1 | 2005 | 148 | 0.240 |
Why?
|
| Sound | 1 | 2005 | 257 | 0.220 |
Why?
|
| Cochlear Nerve | 2 | 2015 | 202 | 0.220 |
Why?
|
| Muscle Contraction | 2 | 2018 | 1200 | 0.190 |
Why?
|
| Evoked Potentials, Motor | 1 | 2004 | 464 | 0.190 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2021 | 25 | 0.190 |
Why?
|
| Endolymphatic Sac | 1 | 2021 | 49 | 0.180 |
Why?
|
| Hearing Loss, Conductive | 2 | 2016 | 159 | 0.180 |
Why?
|
| Otolaryngology | 2 | 2016 | 693 | 0.150 |
Why?
|
| Cogan Syndrome | 1 | 2017 | 10 | 0.150 |
Why?
|
| Scala Tympani | 1 | 2017 | 35 | 0.150 |
Why?
|
| Vestibulocochlear Nerve | 1 | 2017 | 115 | 0.150 |
Why?
|
| Labyrinthitis | 1 | 2017 | 32 | 0.140 |
Why?
|
| Foreign-Body Reaction | 1 | 2017 | 157 | 0.130 |
Why?
|
| Spiral Ganglion | 1 | 2017 | 177 | 0.130 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2016 | 139 | 0.130 |
Why?
|
| Auditory Pathways | 1 | 2017 | 237 | 0.130 |
Why?
|
| Neural Inhibition | 2 | 2019 | 588 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2021 | 828 | 0.120 |
Why?
|
| Prosthesis Implantation | 1 | 2019 | 591 | 0.120 |
Why?
|
| Abnormalities, Multiple | 2 | 2011 | 1422 | 0.110 |
Why?
|
| Ear, Middle | 1 | 2016 | 339 | 0.110 |
Why?
|
| Anesthetics | 1 | 2019 | 523 | 0.110 |
Why?
|
| Reflex | 1 | 2015 | 375 | 0.110 |
Why?
|
| Adult | 29 | 2024 | 221083 | 0.110 |
Why?
|
| Retrospective Studies | 20 | 2022 | 80673 | 0.110 |
Why?
|
| Otosclerosis | 1 | 2013 | 113 | 0.100 |
Why?
|
| Brain Stem | 1 | 2017 | 858 | 0.100 |
Why?
|
| Cochlear Nucleus | 1 | 2012 | 60 | 0.100 |
Why?
|
| Ear Diseases | 1 | 2014 | 181 | 0.100 |
Why?
|
| Facial Nerve | 2 | 2013 | 277 | 0.100 |
Why?
|
| Hearing | 3 | 2022 | 501 | 0.100 |
Why?
|
| Middle Aged | 27 | 2019 | 220835 | 0.100 |
Why?
|
| Auditory Threshold | 3 | 2022 | 369 | 0.090 |
Why?
|
| Hearing Loss | 2 | 2013 | 782 | 0.090 |
Why?
|
| Humans | 56 | 2024 | 761098 | 0.090 |
Why?
|
| Male | 35 | 2021 | 360675 | 0.090 |
Why?
|
| POU Domain Factors | 1 | 2010 | 47 | 0.090 |
Why?
|
| Hearing Tests | 2 | 2021 | 121 | 0.090 |
Why?
|
| Audiometry, Pure-Tone | 4 | 2019 | 210 | 0.090 |
Why?
|
| Motor Neurons | 1 | 2015 | 869 | 0.090 |
Why?
|
| Female | 34 | 2021 | 392458 | 0.090 |
Why?
|
| Tinnitus | 1 | 2012 | 196 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2021 | 20600 | 0.080 |
Why?
|
| Infant | 10 | 2024 | 36164 | 0.080 |
Why?
|
| Aged | 19 | 2021 | 169266 | 0.070 |
Why?
|
| Medical Records | 1 | 2013 | 1409 | 0.070 |
Why?
|
| ROC Curve | 3 | 2019 | 3582 | 0.070 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2017 | 2401 | 0.070 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2010 | 386 | 0.070 |
Why?
|
| Child, Preschool | 10 | 2024 | 42217 | 0.070 |
Why?
|
| Endolymphatic Hydrops | 1 | 2006 | 31 | 0.070 |
Why?
|
| Reference Values | 4 | 2019 | 4922 | 0.060 |
Why?
|
| Neonatal Screening | 2 | 2021 | 597 | 0.060 |
Why?
|
| Child | 11 | 2024 | 80134 | 0.060 |
Why?
|
| Young Adult | 8 | 2019 | 59199 | 0.060 |
Why?
|
| Treatment Outcome | 9 | 2024 | 64670 | 0.050 |
Why?
|
| Syncope | 1 | 2006 | 428 | 0.050 |
Why?
|
| Prospective Studies | 7 | 2019 | 54419 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 2691 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2014 | 41486 | 0.050 |
Why?
|
| Pressure | 1 | 2005 | 1152 | 0.050 |
Why?
|
| Audiometry, Speech | 1 | 2001 | 11 | 0.050 |
Why?
|
| Transducers | 1 | 2022 | 244 | 0.050 |
Why?
|
| Adolescent | 7 | 2018 | 88271 | 0.050 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2001 | 845 | 0.050 |
Why?
|
| Hair Cells, Auditory, Outer | 1 | 2001 | 98 | 0.040 |
Why?
|
| Hair Cells, Auditory, Inner | 1 | 2001 | 197 | 0.040 |
Why?
|
| Electrodes | 1 | 2021 | 611 | 0.040 |
Why?
|
| Infant, Newborn | 5 | 2021 | 26187 | 0.040 |
Why?
|
| Sound Spectrography | 1 | 2019 | 113 | 0.040 |
Why?
|
| Logistic Models | 1 | 2013 | 13254 | 0.040 |
Why?
|
| Equipment Design | 1 | 2005 | 3509 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2022 | 756 | 0.040 |
Why?
|
| Basilar Membrane | 1 | 2017 | 50 | 0.040 |
Why?
|
| Bionics | 1 | 2017 | 46 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 749 | 0.030 |
Why?
|
| Audiometry, Evoked Response | 1 | 1996 | 45 | 0.030 |
Why?
|
| Anesthetics, Intravenous | 1 | 2019 | 394 | 0.030 |
Why?
|
| Meningitis | 1 | 1997 | 217 | 0.030 |
Why?
|
| Vestibular Diseases | 1 | 2018 | 231 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 2017 | 244 | 0.030 |
Why?
|
| North Carolina | 1 | 2016 | 324 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 2001 | 710 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2018 | 6224 | 0.030 |
Why?
|
| Consensus | 1 | 2024 | 3133 | 0.030 |
Why?
|
| Conscious Sedation | 1 | 2019 | 533 | 0.030 |
Why?
|
| Ear | 1 | 2015 | 172 | 0.030 |
Why?
|
| Gastrula | 1 | 1994 | 82 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 36418 | 0.030 |
Why?
|
| Embryonic Induction | 1 | 1994 | 151 | 0.030 |
Why?
|
| Anesthetics, Inhalation | 1 | 2019 | 572 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2011 | 22157 | 0.030 |
Why?
|
| Age Factors | 2 | 2011 | 18385 | 0.030 |
Why?
|
| Propofol | 1 | 2019 | 602 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 1818 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2019 | 14676 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2017 | 839 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 2019 | 1174 | 0.020 |
Why?
|
| Disease Progression | 2 | 2019 | 13506 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 1994 | 1750 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15634 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2016 | 1204 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 9455 | 0.020 |
Why?
|
| Electrodiagnosis | 1 | 1989 | 148 | 0.020 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 15845 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1994 | 1964 | 0.020 |
Why?
|
| Syndrome | 1 | 2012 | 3269 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 30006 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 58946 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5249 | 0.020 |
Why?
|
| Facial Paralysis | 1 | 1989 | 346 | 0.020 |
Why?
|
| Sensory Thresholds | 1 | 2006 | 377 | 0.010 |
Why?
|
| Cognition | 1 | 2022 | 6987 | 0.010 |
Why?
|
| Reflex, Acoustic | 1 | 2004 | 34 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 4060 | 0.010 |
Why?
|
| Prevalence | 1 | 2021 | 15717 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 15308 | 0.010 |
Why?
|
| Medicare | 1 | 2021 | 6775 | 0.010 |
Why?
|
| Vertigo | 1 | 2004 | 202 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2015 | 6225 | 0.010 |
Why?
|
| United States | 2 | 2021 | 72337 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 2478 | 0.010 |
Why?
|
| Phonetics | 1 | 2001 | 198 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2006 | 2256 | 0.010 |
Why?
|
| Noise | 1 | 2001 | 290 | 0.010 |
Why?
|
| Speech Discrimination Tests | 1 | 1997 | 35 | 0.010 |
Why?
|
| Ossification, Heterotopic | 1 | 1997 | 235 | 0.010 |
Why?
|
| Ectoderm | 1 | 1994 | 137 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 20120 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1994 | 1544 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1994 | 657 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2001 | 2106 | 0.010 |
Why?
|
| Mesoderm | 1 | 1994 | 673 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1994 | 1900 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1996 | 3419 | 0.010 |
Why?
|
| Forecasting | 1 | 1995 | 2928 | 0.000 |
Why?
|
| Nerve Degeneration | 1 | 1989 | 747 | 0.000 |
Why?
|
| Respiration, Artificial | 1 | 1995 | 2630 | 0.000 |
Why?
|
| Nerve Regeneration | 1 | 1989 | 796 | 0.000 |
Why?
|
| Critical Illness | 1 | 1996 | 2709 | 0.000 |
Why?
|
| Action Potentials | 1 | 1989 | 1834 | 0.000 |
Why?
|
| Gene Expression | 1 | 1994 | 7567 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1995 | 12058 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1994 | 11066 | 0.000 |
Why?
|
| Risk Factors | 1 | 1995 | 74219 | 0.000 |
Why?
|
| Mice | 1 | 1994 | 81324 | 0.000 |
Why?
|
| Animals | 1 | 1994 | 168083 | 0.000 |
Why?
|